000 04264nam a22003855i 4500
001 81488
003 ES-MaUEC
005 20230207040332.0
007 cr nn 008mamaa
008 150801s2015 gw | s |||| 0|eng d
020 _a9783319211008
024 7 _a10.1007/978-3-319-21100-8
_2doi
050 4 _aRC280.T5
_bH863 2015
245 1 0 _aHuman Papillomavirus (HPV)-Associated Oropharyngeal Cancer
_cedited by Daniel L. Miller, M. Sharon Stack.
250 _a1st ed. 2015.
260 _aCham, Switzerland
_bSpringer
_c2015
300 _a1 recurso en línea (VIII, 314 páginas)
_b29 ilustraciones, 22 ilustraciones en color
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
505 0 _aEpidemiology of HPV-Associated Oropharyngeal Squamous Cell Carcinoma -- Behavioral Correlates of HPV-Associated Oropharyngeal Squamous Cell Carcinomas -- Racial Disparities in Oropharyngeal Cancer -- HPV Virology: Cellular Targets of HPV Oncogenes and Transformation -- Papillomavirus Replication -- MicroRNA Profiles of HPV-AssociatedÂ{u03F2}opharyngeal Squamous Cell Carcinoma (OPSCC) -- Targeting the PI3K-mTOR Signaling Circuitry in HPV-Associated Oral Malignancies: Novel Precision Molecular Therapies -- Mutational Profile of HPV-Positive HNSCC -- Clinical Presentation of HPV-driven Oropharyngeal Carcinoma -- Differences and Similarities between HPV-Associated OPSCC and Cervical Cancer -- Surgical Perspective in the Management of Oropharyngeal Cancer -- HPV and Radiation Sensitivity -- The Role of Immune Modulation in the Carcinogenesis and Treatment of HPV-associated Oropharyngeal Cancer.
520 3 _aHead and neck squamous cell carcinoma (HNSCC), the sixth most prevalent cancer worldwide, remains a very difficult disease to treat and cure despite intensive investigation into molecular etiologies and tumor progression pathways. Due to public health efforts encouraging smoking cessation, the overall incidence of HNSCC has decreased in recent years in many countries. Â{u9BA0} contrast, the incidence of oropharyngeal squamous cell carcinoma (OPSCC) has increased significantly, and this subtype of HNSCC is commonly associated with human papillomavirus (HPV) infection.Â{u036F}reover, individuals with HPV-positive OPSCC are generally younger and are frequently non-smokers, suggesting that HPV-associated OPSCC represents a distinct biologic entity. This volume summarizes the spectrum of current HPV-associated OPSCC research from the fundamental basic science to translational surgery and treatment approaches. Chapters are contributed by authoritative leaders in the fields of research and clinical care. Initial chapters address epidemiology, behavioral correlates of HPV infection, and racial disparities in oropharyngeal cancer. This is followed by chapters detailing HPV virology with focus on viral transformation, viral replication, and host response to viral infection. The molecular biology of HPV-associated OPSCC is investigated in chapters detailing alterations in signaling networks and unique mutational profiles of human tumors. Clinical presentation, surgical perspectives, and treatment paradigms specific to HPV-associated OPSCC conclude the volume.This comprehensive volume provides an up-to-date overview of both scientific discovery and clinical management of this emerging public health problem.
710 2 _aSpringerLink (Online service)
_0Local
_9106996
942 _2lcc
_cLE
988 _aEBOOK, EBSPRINGER, asignarmaterias_11febrero
650 0 _9405049
_aMicrobiología médica
650 7 _aVirología
_2embne
_9413113
650 7 _aInmunología
_2embne
_9138330
700 1 _aMiller, Daniel L
_eeditor literario
_993948
_0Local
700 1 _aStack, M. Sharon
_eeditor literario
_993949
_0Local
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-21100-8
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907 _a.b12900783
_b10-10-17
_c18-01-16
998 _am
_a_alco
_a_vill
_b - -
_cm
_dz
_e-
_feng
_ggw
_h0
945 _aRC280.T5 H863 2015 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11570404
_z06-04-17
999 _c81488
_d81488
_x1